Pain interventions can lessen cancer-causing pain and often lead to a reduction in opioid prescriptions. A Pain Management specialist highlights the intrathecal pump and other interventions.
Findings of this milestone investigation suggest that analgesia may not be the appropriate therapy goal in central pain syndromes and that neuromodulation should focus on pain-related suffering and disability.
Although fibromyalgia has no anatomic lesions, it’s marked by neurological dysfunction — qualifying it as a neuropathic disorder. Linking it to central sensitization can increase the array of treatment options.
Promising research at Cleveland Clinic shows that microglial inflammation is a common, and potentially treatable, pathway for neuropathic pain and other treatment-resistant neuroinflammatory conditions, including Alzheimer disease.